BAILLIE T. A, 1988, Chemical Research Toxicology, 1, 195, 10.1021/tx00004a001
BAILLIE T. A., 1995, Valproic acid: chemistry and biotransformation, pp. 589
CHILCOTT J., 2001, Clinical Therapy, 23, 1792, 10.1016/S0149-2918(00)80078-8
ECKLAND D. A., 2000, Experimental Clinical Endocrinology Diabetes, 108, S234—S242
EPIFANIO R., 1988, Tetrahedron Letters, 29, 6403, 10.1016/S0040-4039(00)82357-6
EVANS P. A., 1996, Synthetic Communications, 26, 4685, 10.1080/00397919608004794
FIESER, M. and FIESER, L. F. 1967, Reagents for Organic Synthesis (New York: Wiley).
KASSAHUN K., 2001, Chemical Research Toxicology, 14, 62, 10.1021/tx000180q
KIYOTA Y., 1997, Arzneim-Forschl Drug Research, 47, 22
KRIETER P. A., 1994, Drug Metabolism and Disposition, 22, 625
MAESHIBA Y., 1997, Arzneim-ForschlDrug Research, 47, 29
MUDALIAR S., 2001, Annual Review of Medicine, 52, 239, 10.1146/annurev.med.52.1.239
SHINSEISHIRYO GAIYO THE, 2000, Medical review for pioglitazone in support of an indication for diabetes
SMITH P. K., 1985, Analytical Biochemistry, 150, 76, 10.1016/0003-2697(85)90442-7
SOHDA T., 1995, Chemical and Pharmaceutical Bulletin, 43, 2168, 10.1248/cpb.43.2168
SOOD V., 2000, Diabetes Technology Therapy, 2, 429, 10.1089/15209150050194297
TANIS S., 1996, Journal of Medicinal Chemistry, 39, 5053, 10.1021/jm9605694
ZHONG W. Z., 1989, Journal of Chromatography, 490, 377, 10.1016/S0378-4347(00)82795-4
